AU513684B2 - Soluble rubella antigen - Google Patents

Soluble rubella antigen

Info

Publication number
AU513684B2
AU513684B2 AU33181/78A AU3318178A AU513684B2 AU 513684 B2 AU513684 B2 AU 513684B2 AU 33181/78 A AU33181/78 A AU 33181/78A AU 3318178 A AU3318178 A AU 3318178A AU 513684 B2 AU513684 B2 AU 513684B2
Authority
AU
Australia
Prior art keywords
rubella antigen
soluble rubella
soluble
antigen
rubella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU33181/78A
Other versions
AU3318178A (en
Inventor
J. W. Safford, Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU3318178A publication Critical patent/AU3318178A/en
Application granted granted Critical
Publication of AU513684B2 publication Critical patent/AU513684B2/en
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/20Rubella virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/36011Togaviridae
    • C12N2770/36211Rubivirus, e.g. rubella virus
    • C12N2770/36234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/36011Togaviridae
    • C12N2770/36211Rubivirus, e.g. rubella virus
    • C12N2770/36251Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU33181/78A 1977-03-01 1978-02-10 Soluble rubella antigen Expired AU513684B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77323177A 1977-03-01 1977-03-01
USUS773231 1977-03-01

Publications (2)

Publication Number Publication Date
AU3318178A AU3318178A (en) 1979-08-16
AU513684B2 true AU513684B2 (en) 1980-12-18

Family

ID=25097600

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33181/78A Expired AU513684B2 (en) 1977-03-01 1978-02-10 Soluble rubella antigen

Country Status (9)

Country Link
JP (1) JPS53107414A (en)
AU (1) AU513684B2 (en)
CA (1) CA1087983A (en)
CH (1) CH639207A5 (en)
DE (1) DE2808615A1 (en)
FR (1) FR2382461A1 (en)
GB (1) GB1592825A (en)
NL (1) NL7802216A (en)
SE (1) SE7802069L (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2514367A1 (en) * 1981-10-08 1983-04-15 Pasteur Institut Detection of pathogenic germs in drinking water, urine etc. - uses specific immuno-adsorbents e.g. polyacrylamide-agarose coupled with specific antibodies
FI841094A (en) * 1984-03-19 1985-09-20 Univ Tennesee Research Corp VIRUSANTIGEN BUNDEN VID EN BAERARE, DESS FRAMSTAELLNING OCH ANVAENDNING.
JPS6147566A (en) * 1984-08-13 1986-03-08 Tetsuo Tomiyama Antirubella virus antibody sensitized corpuscle and measurement of antirubella virus antibody
JPS6153569A (en) * 1984-08-24 1986-03-17 Tetsuo Tomiyama Antirubella virus antisensitized latex and measurement of antirubella virus antibody using the same
JPH03127305U (en) * 1990-04-04 1991-12-20
JPH0412201U (en) * 1990-05-23 1992-01-31

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2111120C3 (en) * 1970-03-11 1974-10-17 Takeda Chemical Industries Ltd Process for the production of rubella virus hemagglutination antigen

Also Published As

Publication number Publication date
CA1087983A (en) 1980-10-21
NL7802216A (en) 1978-09-05
AU3318178A (en) 1979-08-16
SE7802069L (en) 1978-09-02
DE2808615A1 (en) 1978-09-07
FR2382461A1 (en) 1978-09-29
JPS53107414A (en) 1978-09-19
CH639207A5 (en) 1983-10-31
JPS6231301B2 (en) 1987-07-07
GB1592825A (en) 1981-07-08

Similar Documents

Publication Publication Date Title
AU518983B2 (en) Hairspray
AU513665B2 (en) Lidocaine antigens and antibodies
AU3409978A (en) 4-acylaminophenyl-ethanolamines
AU3506678A (en) Polyetheramide-acids
AU527549B2 (en) Antigen derivatives
AU529128B2 (en) Pneumonococcal vaccine
AU3069177A (en) Inkduct
AU516666B2 (en) Brucella absortus vaccine
AU517395B2 (en) Tumor antigen
AU3347978A (en) Phenyl-benzimidazoyl-furanes
AU521248B2 (en) Receiving device for bruisable objects
AU3216278A (en) Phenylcarbamoyl-pyrazolines
AU3216478A (en) Phenylcarbamoyl-2-pyrazolines
AU513684B2 (en) Soluble rubella antigen
AU3239278A (en) Dithienylalkylamines
AU516708B2 (en) 4-alkylthio-2-trifluoromethylalkanesulfonides
AU3307178A (en) Chloroacetanylides
AU3401278A (en) Sipper-seal
AU3418778A (en) Hydroxylated-1d-2d-methylene-steroids
AU3246878A (en) Arylenedioxy-bis-diketones
SU637698A1 (en) Extensometer
AU3397178A (en) N-hydroxy-n-phosphonomethylglycines
SU659206A1 (en) Classifier
SU612721A1 (en) Classifier
AU3234978A (en) Carbimidocarbonylphenylformamidines